Data show use of Insulet's tubeless, closed-loop Omnipod insulin management system for two to three days in children aged 2 to 6 with type 1 diabetes led to 32% more time spent in range over 24 hours and 47% more time in range with low glucose levels overnight. The patients received treatment with the device following a week of standard therapy and exercised for over half an hour daily.
Data show positive results for Insulet's Omnipod in children
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.